Guillaume Rémy advises Gleamner and its 3 co-founders in the context of their EUR 1.5M fundraising with first tier investment funds and renowned business angels.
Launched in 2017, Gleamer intends to disrupt the sector of radiology with its artificial intelligence platform providing an automatized analysis of medical images and generating detailed feedbacks.
This fund raising will allow the hiring of staff by Gleamer, the finalization of its product development and will enable the company to obtain its CE and FDA homologations.